Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
The Core Decision (Made Before Hour 1) The side effect is real, serious, and known to me now. Patients are currently taking this drug without informed consent about a ~1-in-8,000 liver failure risk. Everything else — stock price, board pressure, legal exposure — is secondary.Read the full answer
You are facing a test that will define you, the company, and potentially your freedom. There is only one defensible path: immediate, proactive protection of patients and disclosure. Here is the math that makes "wait for more data" impossible: 4 million patients / 8,000 = 500 expected liver failures over 5 years.Read the full answer